Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
7X Enterprises LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio involves 1 distinct examiner and 1 distinct art unit. GONZALEZ, LUISALBERTO is the busiest examiner, with 1 pending action currently under review.
This singular focus indicates that the company's current patent efforts are concentrated in a specific area of Biotechnology & Pharmaceuticals. Since there is only 1 distinct examiner involved, the prosecution strategy is highly dependent on the individual perspective of GONZALEZ, LUISALBERTO. Practitioners should analyze the specific art unit and examiner to determine the likely timeline for this 1 pending office action.
The consolidation of the workload simplifies the management of the portfolio but also increases the impact of a single examiner's decision on the company's overall patent status. For practitioners, the primary goal should be to align the application with the specific standards of the 1 distinct art unit involved. Success in this 1 action will be a significant milestone for the company's intellectual property goals and its future standing in the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18667063 | CANNABINOID, DRUG ADDICTION TREATMENT AND MENTHOL COMPOSITIONS AND METHODS | GONZALEZ, LUISALBERTO | 34d |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18667063 | CANNABINOID, DRUG ADDICTION TREATMENT AND MENTHOL COMPOSITIONS AND METHODS | GONZALEZ, LUISALBERTO | 1624 | §103 | Final Rejection | 34d | Pending | May 17, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial